Zimmer Biomet

Who are Zimmer Biomet's decision-makers?

Zimmer Biomet is led by Ivan Tornos. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, privacy, compliance, finance, clinical or scientific stakeholders, and implementation owners.

CEO
Ivan Tornos
CFO/key exec
Suketu Upadhyay
Founded
1927
Employees
20,000+
HQ
Warsaw, IN
Status
NYSE: ZBH
  • Ivan TornosPresident and Chief Executive OfficerCEO since 2023Leads orthopedics, sports medicine, extremities, and digital surgery.
  • Suketu UpadhyayExecutive Vice President and Chief Financial OfficerCFO since 2023Oversees finance and operating performance.
  • Sang YiGroup President, Asia PacificRegional business leaderLeads a major international growth region.
  • Wilfred van ZuilenGroup President, EMEARegional business leaderLeads commercial execution across Europe, Middle East, and Africa.

Who leads Zimmer Biomet?

Zimmer Biomet's leadership team combines enterprise healthcare operations, finance, R&D, clinical, product, technology, legal, manufacturing, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.

Who actually makes buying decisions at Zimmer Biomet?

Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, information security, privacy, compliance, quality, and implementation owners. Clinical, reimbursement, regulatory, or scientific stakeholders become essential whenever the purchase touches patient care, regulated data, clinical evidence, medical products, lab workflows, or payer/provider economics.

How is Zimmer Biomet organized as it scales?

Zimmer Biomet operates through product, therapeutic-area, regional, manufacturing, commercial, and corporate functions. That creates multiple entry points, but enterprise standards for security, privacy, compliance, contracting, vendor risk, and data governance can still control the final approval path.

As of June 2026.Sources:Zimmer Biomet leadershipZimmer Biomet annual reports

Zimmer Biomet — frequently asked questions

Agent CTA Background

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.